Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)

NCT01691326 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluzone®: Influenza Virus Vaccine, No Preservative: Pediatric Dose
BIOLOGICAL: Fluzone®; Influenza Virus Vaccine, No Preservative

Sponsor

Sanofi Pasteur, a Sanofi Company